Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

CMV infection increases the risk of GvHD after bone marrow transplants.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Combining hair follicle transplantation and a 308 nm excimer laser effectively treats perioral vitiligo without unwanted hair growth.

The guideline provides recommendations for managing alopecia areata effectively.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Men with Addison disease should be screened for X-linked adrenoleukodystrophy if they have hair loss.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Bortezomib chemotherapy can cause temporary skin rashes.

Low-level laser therapy combined with NB-UVB is a safe and potentially effective treatment for stable vitiligo.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Rituximab may cause skin issues, but baricitinib can help improve them.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

SVF and PRP improve hair loss, but SVF causes more side effects.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.